The Clinical Investigations Department at BC Cancer was established to be the central point of contact for investigators wanting to undertake clinical research at BC Cancer. 

We are putting together a team of dedicated and recognized experts to help guide investigators and study teams to achieve the highest quality research.  The goals of the department are to improve the quality and productivity of clinical research at BC Cancer while encouraging a culture of innovation, responsibility and accountability.  The Clinical Investigations Department is committed to ensuring BC Cancer clinical research is operationally efficient and of high quality.  We will achieve this by standardizing practices across the province, providing comprehensive education programs and quality and metrics reporting and administrative support for clinician-investigators.

From Research to Treatment

Many of the treatments we have in Canada today are available thanks to people who volunteer to take part in a clinical trial​.  
Find out more about clinical trials

News & Events

Scientists discover high-risk form of endometrial cancer — and how to test for it — using AI

​Dr. Jessica McAlpine, surgeon-scientist, BC Cancer and Vancouver General Hospital and professor and Dr. Chew Wei Chair in Gynaecologic Oncology at UBC

Using artificial intelligence (AI) to spot patterns across thousands of cancer cell images, the researchers have pinpointed a distinct subset of endometrial cancer that puts patients at much greater risk of recurrence and death, but would otherwise go unrecognized by traditional pathology and molecular diagnostics.

First systemic therapy patient enrolled in a clinical trial in Prince George

BC Cancer – Prince George celebrated a significant milestone in early 2024 with the opening of a new clinical trial called CIRCULATE-NORTH-AMERICA, or CRC10, which marked the first time a systemic therapy clinical trial has been offered in northern B.C. to people with cancer. Since opening CRC10 in January 2024, the team in Prince George has enrolled two patients in this study.

Robert Olson and Bernie Eigl honoured for their excellence in clinical trials

Dr. Robert Olson, executive medical director at BC Cancer – Prince George, and Dr. Bernie Eigl, deputy head, department of clinical research at BC Cancer, have been honoured with 2024 Clinical Trials BC Awards for their outstanding contributions to the clinical trials community in British Columbia and beyond. 

Clinical Trials BC, part of Michael Smith Health Research BC, recognizes individuals and organizations who have made significant contributions to strengthening BC’s clinical trials ecosystem through these annual awards. 

Back to top